Pathalys Pharma

Raleigh, NC · Founded 2021 · Privately Held (backing)

Developer of advanced therapeutics designed to address unmet needs in the management of late-stage chronic kidney diseases. Pathalys Pharma is based in Raleigh, NC and was founded in 2021. Its last known valuation is $295 million. It has raised $266 million.

Last price · $/share

—

Implied valuation

$295.0M

Total raised

$266.0M

Last round

—

How much has Pathalys Pharma raised?

$266.0Macross 0 recorded rounds

Free account

More of Pathalys Pharma with a free account

·The complete investor list: 12 names
·Watch Pathalys Pharma: the Monday email on marks, rounds and moves

Create free account

No card required

Membership and data by Private Market View

Pathalys Pharma investors

12 investors are on record for Pathalys Pharma, including KB Investment, OrbiMed, Samsara BioCapital and The Carlyle Group. By type, the record holds 2 venture capital firms, 2 private equity firms and 1 hedge fund.

For fundraisers

Raising for a company like Pathalys Pharma?

12 investors have backed Pathalys Pharma.

See all 12 investors →

Frequently asked about Pathalys Pharma

How much has Pathalys Pharma raised?: Pathalys Pharma has raised $266.0M in total across 0 recorded funding rounds.